1-3 of 3
Christian Müller
Close
Sort by
Journal Articles

Incorporation of the Bone Marker Carboxy-Terminal Telopeptide of Type-1 Collagen (ICTP) into a Combined ISS-ICTP Score Improves the Prognostic Significance of the ISS in Newly Diagnosed Symptomatic Multiple Myeloma and Identifies a Very Low Risk Group Which Has No Benefit from High-Dose Therapy

Christian Jakob, MD, Peter Liebisch, MD, Ulrike Heider, MD, Martin Kaiser, MD, Jan Sterz, MD, Jessica Rademacher, MD, Claudia Fleissner, MD, Christian Müller, MD, Orhan Sezer, MD
Journal: Blood
Blood (2008) 112 (11): 2721.
https://doi.org/10.1182/blood.V112.11.2721.2721
Published: 2008
Journal Articles

Treatment of Bortezomib Increases Osteoblast Function in Patients with Multiple Myeloma.

Ulrike Heider, MD, Martin Kaiser, MD, Christian Müller, MD, Carsten-Oliver Schulz, MD, Christian Jakob, MD, Ivana Zavrski, MD, Jan Eucker, MD, Jan Sterz, MD, Lorenz Kleeberg, MD, Kurt Possinger, MD, Orhan Sezer, MD
Journal: Blood
Blood (2005) 106 (11): 3457.
https://doi.org/10.1182/blood.V106.11.3457.3457
Published: 2005
Journal Articles

Oral isobutyramide reduces transfusion requirements in some patients with homozygous β-thalassemia

Clinical Trials & Observations
Susanne Reich, Christoph Bührer, Günter Henze, Dieter Ohlendorf, Michael Mesche, Pranav Sinha, Andreas Kage, Christian Müller, Barbara Vetter, Andreas E. Kulozik
Journal: Blood
Blood (2000) 96 (10): 3357–3363.
https://doi.org/10.1182/blood.V96.10.3357
Published: 2000